Citi lowered the firm’s price target on Procter & Gamble to $181 from $200 and keeps a Buy rating on the shares. Despite “well-telegraphed headwinds,” Procter & Gamble delivered a fiscal Q3 miss net of a small earnings beat and lowered fiscal 2025 guidance, the analyst tells investors in a research note. The firm suspects the company is now past retail destocking headwinds in the U.S. and continues to make sequential progress on China. It lowered estimates but continues to view Procter & Gamble’s execution as solid. Citi closed its negative short-term view on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target lowered to $180 from $190 at BofA
- Procter & Gamble upgraded to Outperform from Sector Perform at RBC Capital
- Procter & Gamble Reports Modest Q3 Growth
- Procter & Gamble’s Strategic Resilience and Growth Amidst Market Challenges: A Buy Recommendation
- Procter & Gamble’s Cautious Optimism in Earnings Call
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue